XENOGENEIC ARTERIAL BYPASS GRAFT

Information

  • Research Project
  • 2230987
  • ApplicationId
    2230987
  • Core Project Number
    R43HL053192
  • Full Project Number
    1R43HL053192-01
  • Serial Number
    53192
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1995 - 28 years ago
  • Project End Date
    3/31/1996 - 28 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1995 - 28 years ago
  • Budget End Date
    3/31/1996 - 28 years ago
  • Fiscal Year
    1995
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/27/1995 - 28 years ago
Organizations

XENOGENEIC ARTERIAL BYPASS GRAFT

DESCRIPTION (Adapted from applicant's abstract): Although the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedures, occasions arise in which it is not possible to use this vein, demanding an alternative method. The investigators propose a feasibility study in canine subjects to determine whether an immunologically modified xenogeneic vessel with recipient endothelium can serve as a replacement of the autogenous saphenous vein. The investigators intend to assess the viability of the tissue modification technique, and seek to optimize endothelial cell seeding. The final object of this effort will be to assess in vivo the biocompatibility of the implant, as well as its overall effectiveness as a graft.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    CRYOLIFE, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    KENNESAW
  • Organization State
    GA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    30144
  • Organization District
    UNITED STATES